Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851382 · ClinicalTrials.gov registry record
Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 29
- Enrollment target
NCT01851382: Completed study, sponsored by National Cancer Institute (NCI).
NCT01851382 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01851382 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
Background: \- Researchers often collect samples from healthy volunteers to further their research. These samples can help better understand serious side effects and complications of transplant treatments in patients. This study will collect saliva samples from healthy volunteers. Objectives: \- To collect saliva and blood samples from healthy volunteers for research studies. Eligibility: \- Healthy men ages 30-70 years for Phase I of the study. Design: * Participants will be screened with a medical history questionnaire. They will also have a brief oral exam to check for any mouth infection. * Participants will provide a saliva sample. The collection process will take about 5 minutes. * No treatment will be given as part of this study.
Primary Outcome
Sample analysis for research.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-05-15 |
| Est. Completion | 2015-02-12 |
What the finished NCT01851382 record still lists
NCT01851382 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01851382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01851382 about?
NCT01851382 is a clinical study titled "Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research". Background: \- Researchers often collect samples from healthy volunteers to further their research. These samples can help better understand serious side effects and complications of transplant treatments in patients. This study will collect saliva samples from healthy volunteers. Objectives: \- ...
What is the current status of trial NCT01851382?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2013-05-15. Estimated completion is 2015-02-12.
Who is sponsoring clinical trial NCT01851382?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI